CPR Invest - GEAR Emerging - A EUR - Acc ISIN : LU1811398467

CPR Invest - GEAR Emerging - A EUR - Acc
Asset class: Equities
YTD
As of 26/08/2026
26.26%
Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.
NAV
As of 26/08/2026
€185.70
SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8
Fund AUM
As of 26/08/2026
€58.28M
“The fund invests in emerging market equities and seeks to outperform the MSCI Emerging Market index over the long term – at least 5 years. The final portfolio includes around a hundred emerging market stocks from all business sectors and with all sizes of market capitalisation. The investment process involves adapting the stock-picking method to market conditions.”
 

NAVs

NAV from 10/11/2018 to 08/26/2026
Select period
Created with Highcharts 11.4.8CPR Invest - GEAR Emerging - A EUR - AccJan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '2675100125150175200225

Performance

Change in NAV in base 100
FundCPR Invest - GEAR Emerging - A EUR - Acc (102.46% over the period)
Select period
Created with Highcharts 11.4.8ABCPR Invest - GEAR Emerging - A EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2650100150200250300
A. Simulation based on the performance from September 24, 2015 to October 10, 2018 of CPR GEAR Emergents - Part P, French Fund absorbed by CPR Invest - GEAR Emerging - A- Acc on October 11, 2018.B. Performance of CPR Invest - GEAR Emerging - A - Acc since its launch date.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
Change in NAV in base 100Rolling performancesYear-on-year return (365 days)Annual returnsRisk indicatorsPerformances Scenarios
FundCPR Invest - GEAR Emerging - A EUR - Acc (102.46% over the period)
Select period
Created with Highcharts 11.4.8ABCPR Invest - GEAR Emerging - A EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2650100150200250300
A. Simulation based on the performance from September 24, 2015 to October 10, 2018 of CPR GEAR Emergents - Part P, French Fund absorbed by CPR Invest - GEAR Emerging - A- Acc on October 11, 2018.B. Performance of CPR Invest - GEAR Emerging - A - Acc since its launch date.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.

Portfolio Analysis

Repartition 07/31/2026
Sector allocationGeographical breakdown (Source: Amundi)Main Lines in Portfolio (Source: Amundi)Currency
Created with Highcharts 11.4.8Values41.65​41.6520.16​20.167.58​7.587.26​7.266.26​6.264.77​4.774.36​4.363.50​3.502.16​2.161.92​1.9237.76​37.7621.11​21.118.90​8.906.99​6.996.47​6.473.05​3.056.11​6.112.74​2.743.67​3.671.10​1.10PortfolioBenchmark02468101214161820222426283032343638404244Information TechnologyFinancialsConsumer DiscretionaryCommunication ServicesIndustrialsConsumer StaplesMaterialsHealth CareEnergyReal EstateHighcharts.com

Management commentary

Effective date: 30/09/2024Emerging markets (EM) finished the month up by 5.8% (in EUR) and outperformed developed markets (1%). EMEA (1.53%) underperformed the region, as did Latin America (-0.71%). On the Asian side, the performance is 7.13% (EUR).

In September, the MSCI EM surged, significantly outperforming the developed market, driven by several favorable macroeconomic catalysts. The Fed began its easing cycle with a 50 basis point rate cut, which exceeded the market's expectations of a 25 basis point cut. Taking advantage of the Fed's decision, central banks of emerging countries, including China's PBoC, implemented a global monetary easing. Moreover, the September Politburo meeting surprised the market by focusing on key economic issues and urgent policy measures to be taken. The weakening of the US dollar (-0.9%) throughout the month further boosted the stocks of emerging countries. In the 3rd quarter of 2024, the MSCI EM recorded gains of +7.8%, surpassing the MSCI DM by +1.8%.

Emerging market stocks recorded a net outflow of -$19.2bn in 2024.

We note a positive sector effect, particularly a good contribution from consumer discretionary and materials but negative in the communication services and energy sectors. The country effect was also positive, especially with a good contribution from the Netherlands and Hong Kong but negative in China and Poland. We also observe a negative effect from our aggressive factor, with a contribution around -0.50%, and at the same time note a negative effect from our defensive factor showing a contribution of -0.31%. The market capitalization size effect was positive. Over the period under review, we were overweight on the blend factor and underweight on the price momentum factor. At the stock level, we find very good contributors to performance such as Kuaishou Technology Class B (OW, 38.2%), Trip.com Group Ltd. (OW, 31.7%), IMEIK Technology Development Co., Ltd. Class A (OW, 70.8%), Prosus N.V. Class N (OW, 17.1%).

Characteristics

General data

Inception date
11/10/2018
First Nav Date
24/09/2010
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs2.10% of the value of your investment per year. This percentage is based on actual costs over the last year.€199.69
Transaction costs0.39% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€37.23
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

20.00% annual outperformance of the reference asset 100% MSCI EM (EMERGING MARKETS) NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU1811398467
Bloomberg code
CPIGEAE LX
Reuters code

Investment Objective

“The fund invests in emerging market equities and seeks to outperform the MSCI Emerging Market index over the long term – at least 5 years. The final portfolio includes around a hundred emerging market stocks from all business sectors and with all sizes of market capitalisation. The investment process involves adapting the stock-picking method to market conditions.”
 

Documents

LanguageDocumentsTypeClosing Date
DE
PDF
11/08/2026
EN
PDF
11/08/2026
FR
PDF
11/08/2026
PDF
31/07/2024
PDF
16/04/2026
PDF
31/01/2026
IT
PDF
11/08/2026
EN
PDF
31/07/2026
FR
PDF
31/07/2026
FR
PDF
26/10/2016
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only. Nothing contained in this site constitutes a solicitation or offer by any member of CPR Asset Management to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". CPR Asset Management does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.The Key investor Informations document (KIID) and the prospectus of the fund, as well as the annual and semi-annual reports are available free of charge on the website www.cpram.com and from the Representative or Paying Agents : CACEIS (SWITZERLAND) SA - 35 Route de Signy, CH-1260 Nyon, Suisse or CACEIS Bank, Montrouge, Succursale de Nyon - Route de Signy 35 - CH- 1260 Nyon, Suisse.
© CPR Asset Management 2025
Legal notices Accessibility: non-compliant Cookies preferences